Taiwan's Medigen Vaccine Biologics Corp. (MVC) has applied to begin phase 2 testing of its COVID-19 vaccine, becoming the third local developer seeking permission to test the efficacy of its product on a larger scale, the company said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
China's 'unification benefits' hold no appeal for Taiwanese: MAC
10/25/2025 10:44 PM - Cross-Strait
Taiwan must rely on strength to secure peace: President Lai
10/25/2025 10:35 PM - Business
Trump wrong to have Taiwan chip on his shoulder: Tech writer
10/25/2025 09:38 PM - Society
Taiwan at least 3 months away from regaining ASF-free status: MOA
10/25/2025 09:23 PM - Business
Sentiment among manufacturers improves for 3rd straight month on AI boom
10/25/2025 08:59 PM